Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
QUILLIVANT XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 ) ]. Limitations of Use The use of QUILLIVANT XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), Use in Specific Populations ( 8.4 )].
- generic_name
- methylphenidate hydrochloride
- product_names
- methylphenidate hydrochloride
- ndc
- 24478-321, 24478-321-02, 24478-322, 24478-322-04, 24478-323, 24478-323-05, 24478-324, 24478-324-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en